Acta Dermato Venereologica · 2021 · 144 citations · 20 references
MedicineDermatologyPharmacotherapyAllergyClinical Decision SupportHypersensitivityAtopic DermatitisGuideline ImplementationAtopic Dermatitis EvaluationAtopic Dermatitis PharmacotherapyAtopic Dermatitis TreatmentConsensusLikert Scale DesignThresholdsTreatment Continuation Decisions
Currently no treat-to-target framework to guide systemic treatment in adults with moderate-to-severe atopic dermatitis exists. We sought to reach international consensus through an eDelphi process on a core set of recommendations for such an approach. Recommendations were developed by an international Steering Committee, spanning 3 areas (Guiding Principles, Decision Making, and Outcome Thresholds) and 2 specific time-points; an initial acceptable target at 3 months and an optimal target at 6 months, each based on improvements in patient global assessment plus at least one specific outcome domain. These treat-to-target- orientated recommendations were evaluated by an extended international panel of physicians, nurses and patients. Proposed recommendations were rated using a 9-point Likert scale; for each recommendation, consensus agreement was reached if ≥ 75% of all respondents rated agreement as ≥ 7. Consensus on 16 core recommendations was reached over 2 eDelphi rounds. These provide a framework for shared decision-making on systemic treatment continuation, modification, or discontinuation.
20
Andreas Wollenberg, S. Barbarot, Thomas Bieber et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 1.2K citations · Full text
Medicine, Dermatology, Pediatrics +17
Josef S Smolen, Monika Schöls, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2017 · 676 citations · Full text
Joanne R Chalmers, Kim S Thomas, Christian Apfelbacher et al. · British Journal of Dermatology · 2018 · 160 citations · Full text
Medicine, Dermatology, Pediatrics +15